Financial Supervisory Service Requests Aprogen MED to Submit Revised Merger Securities Report
[Asia Economy Reporter Lee Seon-ae] The Financial Supervisory Service announced on the 31st that it requested Aprogen MED to submit a corrected report following the review of the securities registration statement (merger) submitted on the 22nd. Aprogen MED is currently pursuing a merger with Aprogen, and the Financial Supervisory Service judged that the contents of the securities registration statement were insufficient.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Foreign Media Take Note as Samsung Electronics Averts Strike Crisis: "Concerns Over AI Chip Supply Chain Eased"
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The Financial Supervisory Service stated, “As a result of the review, this applies to cases where the securities registration statement does not properly conform to the required format, or where there are false statements or omissions regarding important matters in the securities registration statement, or where the description or indication of important matters is unclear, thereby hindering investors' reasonable investment decisions or causing significant misunderstandings to investors.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
